ROSSKAMP RALF 4
4 · Dicerna Pharmaceuticals Inc · Filed Jan 4, 2019
Insider Transaction Report
Form 4
ROSSKAMP RALF
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2019-01-02+180,000→ 180,000 totalExercise: $11.77Exp: 2029-01-02→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 monthly installments over the four-year period starting on the last day of January 2019, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.